prodchem
Sep 9, 2026
BASF has just finished modernizing its acid chlorides and chloroformates plant at Ludwigshafen, lifting capacity by roughly 30 percent. The investment lands at an unusual moment for the site. Employee numbers at Ludwigshafen fell below 30,000 in May 2026, the first time that has happened since 1954, even as the complex remains loss-making despite a broader European chemical recovery.
The contrast is worth sitting with. This is not a company retreating uniformly from its largest production hub. It is a company cutting deeply in some areas while directing real capital into others, and the ACCF plant is a clear example of where BASF still sees a business worth expanding.
The Investment Itself
The modernized acid chlorides and chloroformates plant was officially inaugurated on September 2, 2026, representing a low three-digit million-euro investment.
Capacity for the site's roughly 25-product ACCF portfolio increased by approximately 30 percent.
The upgrade included a fundamental renewal of production infrastructure, not simply an incremental debottlenecking.
Applications for this chemistry span pharmaceuticals, crop protection, organic peroxides, coatings, plastics and rubber compounds, giving the investment exposure to several resilient end markets at once.
BASF frames this specifically as a supply reliability play, aimed at customers who depend on ACCF chemistry as a manufacturing input and have limited alternative sourcing options globally.
The Contraction Happening Around It
Set against that investment is a much larger story of retrenchment at the same site. BASF has cut roughly 7,000 jobs worldwide since early 2024, with about two-thirds of those reductions falling in Germany.
Ludwigshafen's full-time employee count dropped below 30,000 for the first time in over 70 years as of May 2026.
CEO Markus Kamieth has described the site as facing a "huge profitability problem," attributing it to declining productivity and persistently low capacity utilisation across multiple production lines.
Despite a broader European chemical sector recovery reflected in BASF's improved 2026 EBITDA guidance, Ludwigshafen specifically has remained unable to turn a profit.
A New Restructuring Phase Is Already Under Way
The workforce reductions are not winding down. BASF's newly announced "CoreShift" program targets up to a 20 percent reduction in net fixed cash costs across its core business by 2029, measured against 2024 levels, with personnel expenses forming a significant share of the planned savings.
Job cuts through the first half of 2026 ran at a pace of roughly 300 to 350 positions per month, and management has indicated that pace is likely to continue for now.
A December 2025 site agreement protects Ludwigshafen from compulsory redundancies through the end of 2028, extendable to 2030 if profitability targets are met, meaning further headcount reduction will rely on attrition and voluntary measures rather than layoffs.
BASF has not yet specified how many additional positions the CoreShift program will eliminate, leaving the total scope of further contraction an open question.
Why the ACCF Investment Still Makes Sense
Selective investment inside a broadly contracting site is not unusual for large chemical producers, but it does signal something about where management sees durable competitive advantage. The ACCF business fits a specific profile.
It serves diversified, resilient end markets rather than a single cyclical customer base.
BASF holds a leading global position in this chemistry, with production concentrated at just two sites worldwide, Ludwigshafen and Yeosu, South Korea.
The entire Ludwigshafen ACCF portfolio has run on renewable electricity credits since 2025, cutting its product carbon footprint by roughly 19 percent, positioning it well against tightening customer sustainability requirements.
That combination, limited global competition, diversified demand and improving sustainability credentials, is a plausible explanation for why this particular unit received fresh capital while other Ludwigshafen assets face closure or continued underutilisation scrutiny.
What Buyers Should Take From This
For customers sourcing ACCF-based intermediates, or any BASF Ludwigshafen product more broadly, this pattern is worth understanding. BASF's own messaging has been consistent that not all of Ludwigshafen is equally at risk, and that assets deemed structurally competitive are receiving continued investment even as the site overall sheds headcount and works through a multi-year cost reduction program.
Buyers should distinguish between product lines BASF has recently invested in, like ACCF, and product lines that have already seen closures, such as the site's caprolactam, ammonia and TDI facilities affected by earlier restructuring rounds. The two categories carry very different supply risk profiles heading into 2027 and beyond.
Featured Product
Found this useful?
Continue Reading
The BASF Apple lawsuit highlights how chemical materials science and consumer technology can collide over intellectual property. Here is how this dispute fits into the wider 2026 chemical-technology patent landscape.
Energy Fuels has begun construction on a $104 million heavy rare earth oxide expansion at its White Mesa Mill, adding terbium and dysprosium production the US currently sources almost entirely from China. Here is what the buildout means for buyers of magnet-grade rare earth materials.
Lotte Chemical is permanently closing its 1.1 million tonne Daesan naphtha cracker as part of a merger with HD Hyundai Chemical, the latest step in South Korea's government-backed effort to cut petrochemical overcapacity. Here is what the closure means for ethylene and polyethylene buyers.
